4//SEC Filing
ALLERGAN INC 4
Accession 0000850693-03-000039
CIK 0000850693operating
Filed
Oct 28, 7:00 PM ET
Accepted
Oct 29, 6:13 PM ET
Size
8.9 KB
Accession
0000850693-03-000039
Insider Transaction Report
Form 4
ALLERGAN INC(AGN)
FELLOWS DAVID A
CVP, Pres., EuroAsia/Africa/ME
Transactions
- Sale
Common Stock
2003-10-28$76.06/sh−20,000$1,521,240→ 8,986.41 total - Exercise/Conversion
Common Stock
2003-10-28$13.01/sh+20,000$260,120→ 28,986.41 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2003-10-28$70.06/sh−20,000$1,401,240→ 21,520 totalExercise: $13.01Exp: 2007-04-22→ Common Stock (20,000 underlying)
Holdings
- 6,332.405(indirect: By Trust)
Common Stock
- 2,314.775(indirect: By Spouse)
Common Stock
- 3,497.71(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Includes shares acquired under the Allergan, Inc. Dividend Reinvestment Plan.
- [F2]Nonqualified stock option granted 4/22/97 under the issuer's incentive compensation plan, which option vested ratably over 4 years from the date of grant.
Documents
Issuer
ALLERGAN INC
CIK 0000850693
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000850693
Filing Metadata
- Form type
- 4
- Filed
- Oct 28, 7:00 PM ET
- Accepted
- Oct 29, 6:13 PM ET
- Size
- 8.9 KB